Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 87-95

  Kraig, Ellen ^a   Pierce, Jessica L ^b   Clarkin, Kimberly Z ^a,b   Standifer, Nathan E ^b   Currier, Patricia ^b   Wall, Katherine A ^c   Infante, Anthony J ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

acetylcholine receptor; immune repertoire; Myasthenia gravis; T cell antigen receptor

Indexed keywords

CD3 ANTIGEN; CHOLINERGIC RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYBRIDOMA; IMMUNIZATION; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HYBRIDOMAS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYASTHENIA GRAVIS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, NICOTINIC;

EID: 0030560756     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00151-8     Document Type: Article

References (42)

1. Acha-Orbea H., Mitchell D.J., Timmerman L., Wraith D.C., Tausch G.S., Waldor M.K., Zamvil S.S., McDevitt H.O., Steinman L. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalitis allows specific immune intervention. Cell. 54:1988;263-273.
2. Arden B., Clark S.P., Kabelitz D., Mak T.W. Mouse T-cell receptor variable gene segment families. Immunogenetics. 42:1995;501-530.
3. Atassi M.Z., Biserka M., Yokoi T., Manshouri Y. Localization of the functional sites on the alpha chain of acetylcholine receptor. Fed. Proc. 46:1987;2538-2547.
4. Bell, J., Rassenti, L., Smoot, S., Smith, K., Newby, C., Hohlfeld, R., Toyka, K., McDevitt, H. and Steinman, L. (1986) HLA-DQ-chain polymorphism linked to myasthenia gravis. Lancet i, 1058-1060.
5. Bellone M., Ostlie N., Lei S., Conti-Tronconi B.M. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the subunits of Torpedo californica and murine acetylcholine receptors. Eur. J. Immunol. 21:1991;2303-2310.
6. + cells sensitized to the nicotinic acetylcholine receptor. J. Immunol. 146:1991;1484-1491.
7. + cells specific for defined epitopes on the acetylcholine receptor in congenic mouse strains. J. Autoimmunity. 5:1992;27-46.
8. Bentley G.A., Boulet G., Karjalainen K., Mariuzza R.A. Crystal structure of the β chain of a T cell antigen receptor. Science. 267:1995;1984-1987.
9. Berman P.W., Patrick J. Experimental myasthenis gravis: a murine system. J. Exptl. Med. 151:1980;204-233.
10. Cheng K.C., Chiang H.J., Wang K., Lee M.K., Yoo T.J., Hood L. Dominant usage of T-cell receptor alpha gene segments from one parent in experimental autoimmune encephalomyelitis induced in F1 mice. Ann. N.Y. Acad. Sci. 756:1995;329-330.
11. Chien Y.H., Gascoigne R.J., Kavaler J., Lee N.E., Davis M.M. Somatic recombination in a murine T-cell receptor gene. Nature. 309:1984;322-326.
12. Chirgwin J.M., Przybla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
13. Christadoss P., Lindstrom J.M., Melvold R.W., Talal N. Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. Immunogenetics. 21:1985;33-39.
14. Christadoss P., Shenoy M., Oshima M., Atassi M.Z. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv. Exp. Med. Biol. 347:1994;65-75.
15. Danska J.S., Livingstone A.M., Paragas V., Ishihara T., Fathman C.G. The presumptive CDR3 regions of both T cell receptor α and β chains determine T cell specificity for myoglobin peptides. J. Exp. Med. 172:1990;27-33.
16. Davis M.M., McHeyzer-Williams M., Chien Y.H. T-cell receptor V-region usage and antigen specificity. The cytochrome c model system. Ann. N.Y. Acad.Sci. 756:1995;1-11.
17. Fields B.A., Ober B., Malchiodi E.L., Lebedeva M.I., Braden B.C., Ysern X., Kim J.-K., Shao X., Ward E.S., Mariuzza R.A. Crystal structure of the Vα domain of a T cell antigen receptor. Science. 270:1995;1821-1824.
18. Gascoigne N.R.J., Chien Y-h., Becker D.M., Kavaler J., Davis M.M. Genomic organization and sequence of T-cell receptor β-chain constant and joining region genes. Nature. 310:1984;387-391.
19. Howell M.D., Winters S.D., Olee T., Powell H.C., Carlo D.J., Brostoff S.W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science. 246:1989;668-670.
20. Infante A.J., Thompson P.A., Krolick K.A., Wall K.A. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:1991;2977-2982.
21. Infante A.J., Levcovitz H., Gordon V., Wall K.A., Thompson P.A., Krolick K.A. Preferential use of a T cell receptor Vβ gene by acetylcholine receptor reactive T cells from myasthenia gravis susceptible mice. J. Immunol. 148:1992;3385-3390.
22. Kappler J.W., Skidmore B., White J., Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. J. Exp. Med. 153:1981;1198-1214.
23. bm12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Scand. J. Immunol. 42:1995;215-225.
24. Koop B.F., Wilson R.K., Wang K., Vernooij B., Zaller D., Kuo C.L., Seto D., Toda M., Hood L. Organization, structure and function of 95 kb of DNA spanning the murine T-cell receptor Cα/Cδ region. Genomics. 13:1992;1209-1230.
25. Krolick K.A., Urso O.E. Analysis of helper-T-cell function by acetylcholine receptor-reactive cell lines of defined AChR-subunit specificity. Cell. Immunol. 105:1987;75-85.
26. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233-284.
27. Malissen M., Minard K., Mjolsness S., Kronenberg M., Goverman J., Hunkapiller T., Prystowsky M.B., Yoshikai Y., Fitch F., Mak T.W., Hood L. Mouse T cell antigen receptor: Structure and organization of constant and joining gene segments encoding the β polypeptide. Cell. 37:1984;1101-1110.
28. Manfredi A.A., Protti M.P., Bellone M., Moiola L., Conti-Tronconi B.M. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis. J. Lab. Clin. Med. 120:1992;13-21.
29. Melms A., Shalke B.C.G., Kirchner T., Mueller-Hermelink H.K., Albert E., Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81:1988;902-908.
30. Olsberg C.A., Maxwell L.C., Mikiten T.M., Krolick K.A. Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor. J. Neuroimmunol. 14:1987;253-266.
31. Pierce J.L., Zborowski K.A., Kraig E., Infante A.J. Highly conserved T cell receptor β chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Int. Immunol. 6:1994;775-783.
32. Shenoy M., Oshima M., Atassi M.Z., Christadoss P. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:1993;230-238.
33. Smith H.P., Le P., Woodland D.L., Blackman M.A. T cell receptor α-chain influences reactivity to Mls-1 in Vβ8.1 transgenic mice. J. Immunol. 149:1992;887-896.
34. Steinman L., Mantegazza R. Prospects for specific immunotherapy in myasthenia gravis. FASEB Journal. 4:1990;2726-2731.
35. Thompson P.A., McAtee R., Infante A.J., Currier P., Beninati W., Krolick K.A. V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis. Int. Immunol. 6:1994;1807-1815.
36. Tournier-Lasserve E., Bach J-F. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models. J. Neuroimmunology. 47:1993;103-114.
37. Utz U., Brooks J.A., McFarland H.F., Martin R., Biddison W.E. Heterogeneity of T-cell receptor alpha-chain complementarity-determining region 3 in myelin basic protein-specific T cells increases with severity of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;5567-5571.
38. b binding, self-nonself discrimination and TCR antagonism. J. Immunol. 152:1994;4526-4536.
39. White J., Blackman M., Bill J., Kappler J., Marrack P., Gold D.P., Born W. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1989;1822-1825.
40. Wraith D.C., McDevitt H.O., Steinman L., Acha-Orbea H. T cell recognition as the target for immune intervention in autoimmune disease. Cell. 57:1989;709-715.
41. b strains. J. Immunol. 154:1995;3603-3610.
42. Zaller D.M., Osman G., Kanagawa O., Hood L. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor Vβ-specific antibodies. J. Exp. Med. 171:1990;1943-1955.